|
 |
Volume 1, Number 2 (July/August 2004) | |||||
Letter from the Editor |
|||||
75 |
Transitioning patients to palliative care The West Clinic, Memphis, TN One of the most challenging tasks for cancer doctors remains transitioning patients to palliative care services at the end of life. Here, community oncologists have the advantage of the strong relationship they have formed with patients and their families throughout the therapeutic partnership.
|
||||
Community Translations |
|||||
77 |
Bortezomib for multiple myeloma This novel proteasome inhibitor appears to improve response rates and survival in patients with progressive multiple myeloma.
|
||||
79 |
Developments in antiemetic therapy Newer agents promise more effective control of chemotherapy-induced nausea and vomiting.
|
||||
Controversies in Patient Management |
|||||
85 |
Oncology and hospice care Medical College of Wisconsin, Milwaukee, WI, and Center for Palliative Studies, San Diego Hospice & Palliative Care, San Diego, CA HMOs pressure doctors to move terminally ill patients into hospice care. Patients and their families often press for one more round of chemotherapy, clinging to the last shreds of hope. Oncologists find themselves caught between urging palliation and quality of life in the probable final days and not wanting to “give up” on their patients. It’s a moral/medical push-and-pull that the authors explore, and our editors debate.
|
||||
Economics/Practice Management |
|||||
93 |
Will partial breast irradiation be a cost-effective alternative to whole breast irradiation in the treatment of early-stage breast cancer? Fox Chase Cancer Center, Philadelphia, PA Accelerated partial breast irradiation is increasingly being used as an alternative to whole breast irradiation after lumpectomy in patients with early-stage breast cancers. But is it more cost-effective?
|
||||
Community Dialogue |
|||||
98 |
The NCCN guidelines: how do they relate to community oncology practice? NCCN’s chief executive officer explains how the organization’s 112 clinical practice guidelines translate to the community setting and how community oncologists can work with the academic and comprehensive cancer centers that make up the NCCN to improve cancer care for all patients.
|
||||
Roundtable |
|||||
103 |
Experts predict more pressure to standardize, measure quality of cancer care
|
||||
Technology |
|||||
105 |
PDA applications: drug reference guides Drug reference guides are an extremely popular resource for physicians who own handheld computers, or PDAs (personal digital assistants). Community Oncology reviews the latest versions of these electronic wizards.
|
||||
Rare Cancers |
|||||
109 |
Extramammary Paget’s disease Pennsylvania Hospital, Philadelphia Extramammary Paget’s disease is a rare epidermal neoplasm characterized by glandular differentiation, an insidious course, and frequent association with an underlying malignancy. It should be suspected in any case of long-standing pruritic lesions that are refractory to the usual steroid and antifungal treatments.
|
||||
Meetings Highlights & Calendar |
|||||
119 |
HMO profits soar, healthcare falters
|
||||
120 |
Meetings Calendar | ||||
Legislative Update |
|||||
123 |
Why Medicare expeditures for cancer drugs are under fire Community Oncology Alliance
| ||||
123 |
Shortcomings and flaws in Medicare coding that affect oncologist practices
| ||||
124 |
Cancer Care Act of 2004 introduced in the Senate
|
||||
Reader Services |
|||||
68 |
Guide for Authors
| ||||
116 |
Community Classifieds
|
||||
© 2004 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. |
|||||
61 kb